Systematic Review of Monitoring Criteria to Interpret CA125 Increments during 1st Line Chemo/Folow-Up Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Monday, November 30, 2015

Systematic Review of Monitoring Criteria to Interpret CA125 Increments during 1st Line Chemo/Folow-Up



open access:

Systematic Review of Monitoring Criteria to Interpret CA125 Increments during First-Line Chemotherapy and the Subsequent Follow-Up Period among Patients with Advanced Epithelial Ovarian Cancer - systematic-review-of-monitoring-criteria-to-interpret-ca125-increments-during-firstline-chemotherapy-and-the-subsequent-followup-period-among-patients-with-advanced-epithelial-ovarian-cancer-jcop-1000101.pdf


Conclusion:
Consistent criteria for indicating disease progression with CA125 could not be defined due to differences in trial design and selection of patients. The most promising criteria should be re-evaluated under similar and standardized conditions. Computer simulation models and change point algorithms may aid in identifying CA125 assessment criteria to be further validated in prospective clinica

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.